Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

69 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The placebo response in myasthenia gravis assessed by quantitative myasthenia gravis score: A meta-analysis.
Frisaldi E, Shaibani A, Vollert J, Ferrero B, Carrino R, Ibraheem HD, Vase L, Benedetti F. Frisaldi E, et al. Among authors: Ferrero B. Muscle Nerve. 2019 Jun;59(6):671-678. doi: 10.1002/mus.26469. Epub 2019 Apr 2. Muscle Nerve. 2019. PMID: 30883809
High-dose intravenous immunoglobulin G treatment of myasthenia gravis.
Ferrero B, Durelli L. Ferrero B, et al. Neurol Sci. 2002 Apr;23 Suppl 1:S9-24. doi: 10.1007/s100720200011. Neurol Sci. 2002. PMID: 12032583 Review.
Pro-inflammatory cytokine and chemokine mRNA blood level in multiple sclerosis is related to treatment response and interferon-beta dose.
Cucci A, Barbero P, Clerico M, Ferrero B, Versino E, Contessa G, Demercanti S, Viglietta E, Di Liberto A, Vai AG, Durelli L. Cucci A, et al. J Neuroimmunol. 2010 Sep 14;226(1-2):150-7. doi: 10.1016/j.jneuroim.2010.05.038. Epub 2010 Jun 23. J Neuroimmunol. 2010. PMID: 20573405 Clinical Trial.
Modified and improved anti-acetylcholine receptor (AchR) antibody assay: comparison of analytical and clinical performance with conventional anti-AChR antibody assay.
Ferrero B, Aimo G, Pagni R, Bergamasco B, Bongioanni MR, Bergamini L, Durelli L. Ferrero B, et al. Clin Chem. 1997 May;43(5):824-31. Clin Chem. 1997. PMID: 9166237
Therapies for exacerbation of myasthenia gravis. The mechanism of action of intravenous high-dose immunoglobulin G.
Ferrero B, Durelli L, Cavallo R, Dutto A, Aimo G, Pecchio F, Bergamasco B. Ferrero B, et al. Ann N Y Acad Sci. 1993 Jun 21;681:563-6. doi: 10.1111/j.1749-6632.1993.tb22941.x. Ann N Y Acad Sci. 1993. PMID: 8357198 No abstract available.
Searching for prognostic factors at the time of thymectomy for myasthenia gravis. Correlation between outcome after long-term follow-up and immunophenotype of thymic and peripheral blood lymphocytes.
Durelli L, Maggi G, Casadio C, Ferri R, Ferrero B, Poccardi G, Dutto A, Bergamini L. Durelli L, et al. Ann N Y Acad Sci. 1993 Jun 21;681:556-60. doi: 10.1111/j.1749-6632.1993.tb22939.x. Ann N Y Acad Sci. 1993. PMID: 8357196 No abstract available.
Total body irradiation for myasthenia gravis: a long-term follow-up.
Durelli L, Ferrio MF, Urgesi A, Poccardi G, Ferrero B, Bergamini L. Durelli L, et al. Neurology. 1993 Nov;43(11):2215-21. doi: 10.1212/wnl.43.11.2215. Neurology. 1993. PMID: 8232932
Autoimmune events during interferon beta-1b treatment for multiple sclerosis.
Durelli L, Ferrero B, Oggero A, Verdun E, Bongioanni MR, Gentile E, Isoardo GL, Ricci A, Rota E, Bergamasco B, Durazzo M, Saracco G, Biava MA, Brossa PC, Giorda L, Pagni R, Aimo G. Durelli L, et al. J Neurol Sci. 1999 Jan 1;162(1):74-83. doi: 10.1016/s0022-510x(98)00299-8. J Neurol Sci. 1999. PMID: 10064173 Clinical Trial.
69 results
Jump to page
Feedback